NCT03237559 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Charafeddine L, El Rafei R, Azizi S, Sinno D, Alamiddine K, Howson CP, Walani SR, Ammar W, Nassar A, Yunis K
Improving awareness of preconception health among adolescents: experience of a school-based intervention in Lebanon. BMC Public Health. 2014 Jul 31;14:774. doi: 10.1186/1471-2458-14-774.
Okka B, Durduran Y, Degerli Kodaz N
Traditional practices of Konya women during pregnancy, birth, the postpartumperiod, and newborn care. Turk J Med Sci. 2016 Feb 17;46(2):501-11. doi: 10.3906/sag-1504-120.

A Descriptive Comparative Study to Assess Knowledge, Attitude and Practice Regarding Eugenics Among Eligible Couples of Selected Area of Ambala, Haryana (India)

Details for clinical trial NCT03237559

Clinical trial NCT03237559 - References